AXE archer materials limited

nucleic acid testing will likely supersede PCR testing as faster...

  1. 7,255 Posts.
    lightbulb Created with Sketch. 1478
    nucleic acid testing will likely supersede PCR testing as faster and more sensitive.

    even if it isn’t ready for COVID, the recent pandemic has shown us the PCR “gold standard” is not adequate and far too costly.

    NATs will be necessary preparation for the next pandemic.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
28.0¢
Change
-0.005(1.75%)
Mkt cap ! $71.35M
Open High Low Value Volume
29.0¢ 29.5¢ 28.0¢ $32.59K 114.1K

Buyers (Bids)

No. Vol. Price($)
3 17601 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.5¢ 58500 2
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
AXE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.